These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30917857)

  • 21. The microbiome and systemic sclerosis: A review of current evidence.
    Tan TC; Noviani M; Leung YY; Low AHL
    Best Pract Res Clin Rheumatol; 2021 Sep; 35(3):101687. PubMed ID: 33849778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple sclerosis and faecal microbiome transplantation: are you going to eat that?
    Wing AC; Kremenchutzky M
    Benef Microbes; 2019 Feb; 10(1):27-32. PubMed ID: 30525949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intestinal dysbiosis and probiotic applications in autoimmune diseases.
    de Oliveira GLV; Leite AZ; Higuchi BS; Gonzaga MI; Mariano VS
    Immunology; 2017 Sep; 152(1):1-12. PubMed ID: 28556916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Research progress of gut microbiota and microbiota-targeted therapy in critical ill patients].
    Xu R; Tan C; Yin J; Pan S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Nov; 30(11):1099-1102. PubMed ID: 30541654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut microbiome in multiple sclerosis: The players involved and the roles they play.
    Shahi SK; Freedman SN; Mangalam AK
    Gut Microbes; 2017 Nov; 8(6):607-615. PubMed ID: 28696139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbial and metabolic multi-omic correlations in systemic sclerosis patients.
    Bellocchi C; Fernández-Ochoa Á; Montanelli G; Vigone B; Santaniello A; Milani C; Quirantes-Piné R; Borrás-Linares I; Ventura M; Segura-Carrettero A; Alarcón-Riquelme ME; Beretta L
    Ann N Y Acad Sci; 2018 Jun; 1421(1):97-109. PubMed ID: 29749635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging pathogenic links between microbiota and the gut-lung axis.
    Budden KF; Gellatly SL; Wood DL; Cooper MA; Morrison M; Hugenholtz P; Hansbro PM
    Nat Rev Microbiol; 2017 Jan; 15(1):55-63. PubMed ID: 27694885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.
    Kanbay M; Onal EM; Afsar B; Dagel T; Yerlikaya A; Covic A; Vaziri ND
    Int Urol Nephrol; 2018 Aug; 50(8):1453-1466. PubMed ID: 29728993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
    Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
    Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Multiple Sclerosis and Commensal Gut Flora].
    Yamamura T
    Brain Nerve; 2016 Jun; 68(6):617-22. PubMed ID: 27279159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut microbiota and host defense in critical illness.
    Jacobs MC; Haak BW; Hugenholtz F; Wiersinga WJ
    Curr Opin Crit Care; 2017 Aug; 23(4):257-263. PubMed ID: 28548992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Microbiome in Connective Tissue Diseases and Vasculitides: An Updated Narrative Review.
    Talotta R; Atzeni F; Ditto MC; Gerardi MC; Sarzi-Puttini P
    J Immunol Res; 2017; 2017():6836498. PubMed ID: 28835902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis.
    Song H; Yoo Y; Hwang J; Na YC; Kim HS
    J Allergy Clin Immunol; 2016 Mar; 137(3):852-60. PubMed ID: 26431583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
    Sun MF; Shen YQ
    Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysbiosis signatures of gut microbiota in coronary artery disease.
    Zhu Q; Gao R; Zhang Y; Pan D; Zhu Y; Zhang X; Yang R; Jiang R; Xu Y; Qin H
    Physiol Genomics; 2018 Oct; 50(10):893-903. PubMed ID: 30192713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Gut Microbiome in Inflammatory Bowel Disease: Lessons Learned From Other Immune-Mediated Inflammatory Diseases.
    Knox NC; Forbes JD; Peterson CL; Van Domselaar G; Bernstein CN
    Am J Gastroenterol; 2019 Jul; 114(7):1051-1070. PubMed ID: 31232832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A bidirectional association between the gut microbiota and CNS disease in a biphasic murine model of multiple sclerosis.
    Colpitts SL; Kasper EJ; Keever A; Liljenberg C; Kirby T; Magori K; Kasper LH; Ochoa-Repáraz J
    Gut Microbes; 2017 Nov; 8(6):561-573. PubMed ID: 28708466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The microbiome in autoimmune diseases.
    De Luca F; Shoenfeld Y
    Clin Exp Immunol; 2019 Jan; 195(1):74-85. PubMed ID: 29920643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of a refractory dysbiotic intestinal pseudo-obstruction in a patient with systemic sclerosis-polymyositis overlap syndrome by intravenous immunoglobulin administration possibly related to gut flora normalisation.
    Kamei R; Yamaoka T; Ikinaga K; Murota H; Shimizu K; Katayama I
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):214-215. PubMed ID: 28229828
    [No Abstract]   [Full Text] [Related]  

  • 40. Gut Dysbiosis in Animals Due to Environmental Chemical Exposures.
    Rosenfeld CS
    Front Cell Infect Microbiol; 2017; 7():396. PubMed ID: 28936425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.